{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:59:32Z","timestamp":1792202372764,"version":"4.4.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.1449","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:34:01Z","timestamp":1536014041000},"page":"e181449","source":"Crossref","is-referenced-by-count":94,"title":["Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent<i>Plasmodium vivax<\/i>Malaria"],"prefix":"10.1001","volume":"1","author":[{"given":"J. Kevin","family":"Baird","sequence":"first","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melva","family":"Louisa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya No. 6, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintis","family":"Noviyanti","sequence":"additional","affiliation":[{"name":"Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenny","family":"Ekawati","sequence":"additional","affiliation":[{"name":"Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal","family":"Elyazar","sequence":"additional","affiliation":[{"name":"Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decy","family":"Subekti","sequence":"additional","affiliation":[{"name":"Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisin","family":"Chand","sequence":"additional","affiliation":[{"name":"Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anggi","family":"Gayatri","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya No. 6, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Instiaty","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya No. 6, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraswati","family":"Soebianto","sequence":"additional","affiliation":[{"name":"Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelzie","family":"Crenna-Darusallam","sequence":"additional","affiliation":[{"name":"Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwi","family":"Djoko","sequence":"additional","affiliation":[{"name":"Army Health Command, East Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bambang Dwi","family":"Hasto","sequence":"additional","affiliation":[{"name":"Army Health Command, East Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubel","family":"Meriyenes","sequence":"additional","affiliation":[{"name":"Army Health Command, East Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wesche","sequence":"additional","affiliation":[{"name":"Certara Strategic Consulting, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erni J.","family":"Nelwan","sequence":"additional","affiliation":[{"name":"Division of Tropical Infectious Diseases, Faculty of Medicine, Universitas Indonesia, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Sutanto","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herawati","family":"Sudoyo","sequence":"additional","affiliation":[{"name":"Eijkman Institute of Molecular Biology, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianto","family":"Setiabudy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Universitas Indonesia, Jalan Salemba Raya No. 6, Central Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"issue":"6","key":"zoi180092r1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","article-title":"Global epidemiology of Plasmodium vivax.","volume":"95","author":"Howes","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"zoi180092r2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1.00003-7","article-title":"Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.","volume":"80","author":"Anstey","year":"2012","journal-title":"Adv Parasitol"},{"issue":"1","key":"zoi180092r3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/CMR.00074-12","article-title":"Evidence and implications of mortality associated with acute Plasmodium vivax malaria.","volume":"26","author":"Baird","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"zoi180092r4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1473-3099(11)70339-5","article-title":"Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.","volume":"12","author":"McGready","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"zoi180092r6","doi-asserted-by":"publisher","first-page":"e0003595","DOI":"10.1371\/journal.pntd.0003595","article-title":"Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.","volume":"9","author":"Adekunle","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"zoi180092r7","doi-asserted-by":"publisher","first-page":"e1001891","DOI":"10.1371\/journal.pmed.1001891","article-title":"Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.","volume":"12","author":"Robinson","year":"2015","journal-title":"PLoS Med"},{"issue":"6","key":"zoi180092r9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4269\/ajtmh.16-0171","article-title":"Diagnosis and treatment of Plasmodium vivax malaria.","volume":"95","author":"Baird","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"zoi180092r10","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.","volume":"9","author":"Howes","year":"2012","journal-title":"PLoS Med"},{"issue":"10","key":"zoi180092r11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.","volume":"14","author":"Price","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"zoi180092r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.011","article-title":"Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art.","volume":"161","author":"Marcsisin","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"2","key":"zoi180092r13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jms.3122","article-title":"Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling.","volume":"48","author":"Avula","year":"2013","journal-title":"J Mass Spectrom"},{"key":"zoi180092r14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1475-2875-12-212","article-title":"The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.","volume":"12","author":"Pybus","year":"2013","journal-title":"Malar J"},{"issue":"2","key":"zoi180092r15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/1389200215666140202215316","article-title":"Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization.","volume":"15","author":"Hicks","year":"2014","journal-title":"Curr Drug Metab"},{"issue":"11","key":"zoi180092r16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I.","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"zoi180092r17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00210-003-0832-2","article-title":"Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.","volume":"369","author":"Zanger","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"14","key":"zoi180092r18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJMc1301936","article-title":"Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.","volume":"369","author":"Bennett","year":"2013","journal-title":"N Engl J Med"},{"key":"zoi180092r19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/1475-2875-13-488","article-title":"The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.","volume":"13","author":"Ingram","year":"2014","journal-title":"Malar J"},{"issue":"3","key":"zoi180092r20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1128\/AAC.01879-12","article-title":"Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.","volume":"57","author":"Sutanto","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"zoi180092r21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12916-015-0535-9","article-title":"Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.","volume":"13","author":"Nelwan","year":"2015","journal-title":"BMC Med"},{"issue":"2","key":"zoi180092r22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/sj.clpt.6100406","article-title":"The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.","volume":"83","author":"Gaedigk","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"zoi180092r23","first-page":"734","article-title":"CYP2D6 phenotyping with dextromethorphan.","volume":"59","author":"Wojtczak","year":"2007","journal-title":"Pharmacol Rep"},{"issue":"3","key":"zoi180092r24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2133\/dmpk.25.243","article-title":"Estimation of the interindividual variability of cytochrome 2D6 activity from urinary metabolic ratios in the literature.","volume":"25","author":"Ito","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"zoi180092r25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/clpt.2010.137","article-title":"Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan.","volume":"88","author":"Abduljalil","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"zoi180092r28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0378-4347(00)83337-X","article-title":"Determination of primaquine in biological fluids by reversed-phase high performance liquid chromatography.","volume":"305","author":"Ward","year":"1984","journal-title":"J Chromatogr A"},{"key":"zoi180092r29","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development\u2014part 2: introduction to pharmacokinetic modeling methods.","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"zoi180092r30","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1038\/psp.2013.24","article-title":"Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose.","volume":"2","author":"Keizer","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"zoi180092r31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00007691-199308000-00007","article-title":"High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection.","volume":"15","author":"Lam","year":"1993","journal-title":"Ther Drug Monit"},{"issue":"1","key":"zoi180092r32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jchromb.2007.11.019","article-title":"Development and validation of a chemical hydrolysis method for dextromethorphan and dextrorphan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients.","volume":"861","author":"Daali","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"zoi180092r33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.fpc.0000239974.69464.f2","article-title":"CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.","volume":"17","author":"Sistonen","year":"2007","journal-title":"Pharmacogenet Genomics"},{"issue":"12","key":"zoi180092r34","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1086\/379714","article-title":"Primaquine for prevention of malaria in travelers.","volume":"37","author":"Baird","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi180092r35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12936-018-2190-z","article-title":"Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.","volume":"17","author":"Baird","year":"2018","journal-title":"Malar J"},{"key":"zoi180092r5","first-page":"1037","volume-title":"Malariology: A Comprehensive Survey of All Aspects of This Group of Diseases From a Global Standpoint","author":"Kitchen","year":"1949"},{"key":"zoi180092r8","volume-title":"Control and Elimination of Plasmodium vivax: A Technical Brief","author":"World Health Organization","year":"2015"},{"key":"zoi180092r26","unstructured":"ISRCTN Registry. CYP2D6 phenotyping in vivax malaria relapsers and non-relapsers in Indonesia. ISRCTN 37956897. http:\/\/www.isrctn.com\/ISRCTN37656897. Accessed June 5, 2018."},{"key":"zoi180092r27","unstructured":"Equator Network. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). https:\/\/www.strobe-statement.org\/fileadmin\/Strobe\/uploads\/checklists\/STROBE_checklist_v4_case-control.pdf. Accessed July 12, 2017."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/4\/e181449\/17306809\/baird_2018_oi_180092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T11:03:18Z","timestamp":1661943798000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.1449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.1449","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]}}}